Bank Of Hawaii
Source: SEC Form 13F · as of Mar 2026Bank Of Hawaii holds 19 biotech & pharma companies tracked by BioSniper, totaling $42.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$42.8M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 34,803 | $8.5M |
| LLYELI LILLY & Co | 6,261 | $5.8M |
| ABBVAbbVie Inc. | 26,176 | $5.7M |
| MRKMerck & Co., Inc. | 42,163 | $5.1M |
| MCKMcKesson Corporation | 3,229 | $2.8M |
| PMPhilip Morris International Inc | 15,544 | $2.6M |
| ABTABBOTT LABORATORIES | 23,516 | $2.4M |
| ARWRARROWHEAD PHARMACEUTICALS, INC. | 20,125 | $1.3M |
| BIIBBIOGEN INC. | 6,839 | $1.3M |
| PFEPFIZER INC | 41,818 | $1.2M |
| GMOptec International, Inc. | 15,007 | $1.1M |
| SNYSanofi | 19,562 | $943K |
| REGNREGENERON PHARMACEUTICALS, INC. | 1,024 | $791K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 2,749 | $744K |
| BMYBRISTOL MYERS SQUIBB CO | 11,900 | $722K |
| GILDGILEAD SCIENCES, INC. | 4,777 | $666K |
| DNTHDianthus Therapeutics, Inc. /DE/ | 7,904 | $663K |
| ABVXAbivax SA | 3,545 | $395K |
| NVONovo Nordisk A/S | 8,313 | $306K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.